BERKELEY, CA — The UC Berkeley Center for the Science of Psychedelics (BCSP) today released the results of its signature 2025 UC Berkeley Psychedelics Survey. The final report, “A Rising Tide of Cautious Support,” examines how U.S. voters perceive psychedelics, and related public policy proposals and educational opportunities, while also exploring attitudes toward those who use psychedelics. The report is available here.
The UC Berkeley Psychedelics Survey is one of the first national public opinion surveys dedicated specifically to tracking attitudes on psychedelics over time. Now in its second administration, it offers researchers, policymakers, educators and journalists a unique window into evolving U.S. public opinion at a pivotal moment for the field. As the U.S. government signals increased interest in this space, like the recent executive order, it’s critical to understand where the public stands on psychedelics and what concerns they hold around their use.
“The BCSP’s mission is to advance psychedelic discovery for the public good,“ says Andrea Venezia, Executive Director of the UC Berkeley Center for the Science of Psychedelics and a lead author of the report. “Conducting this survey reflects our commitment not only to conducting research to help with complex societal issues, but to understanding the broader social and cultural landscape in which that research takes place. If policymakers want to accelerate psychedelic research and related options for the treatment of certain mental health conditions, the need for sound science and public education is more important than ever before.”
The 2025 UC Berkeley Psychedelics Survey reveals a nuanced picture of U.S. voter opinions, in which four themes stood out:
- Growing awareness, but trust is lacking.
74% of U.S. voters report having been exposed to information about psychedelics in the past year, and familiarity with someone who has used psychedelics continues to rise. However, voters report significant uncertainty about where to turn for trustworthy information, and confidence in available sources remains relatively low across the board. - Cautious but growing support for psychedelic policy reform.
Support for scientific research into psychedelics and for highly regulated access — such as in therapeutic or clinical trial settings — is growing. Voters show considerably more enthusiasm for controlled and supervised models of access than for broader decriminalization or recreational use, suggesting that the public is open to psychedelics but wants guardrails in place. - Safety concerns remain widespread.
While awareness of the potential benefits of psychedelics is growing, many voters continue to harbor significant concerns about their safety. Less than 1 in 4 U.S. voters view psychedelics as safer than alcohol or tobacco, and worries about adverse effects and misuse remain common, underscoring the need for clear, evidence-based public education. - Stigmas persist and likely shape public perception.
Despite increasing societal visibility, people who use psychedelics continue to face negative social perceptions from a substantial portion of the public. For example, about 25% of the sample said “addicts” and “irresponsible” described users well and only 16-17% said “moral” or “smart” described them well. These stigmas could be tied to concerns about safety and legality, and may present a meaningful barrier to both public education efforts and policy reform.
To explore these findings further, the BCSP will host a webinar on Wednesday May 27, 2026 at 10am PDT/1pm EDT featuring report authors Andrea Venezia, Tyrone Sgambati and Kuranda Morgan from the UC Berkeley Center for the Science of Psychedelics. Joining as guest speaker is Michelle Priest, co-principal investigator for the RAND Psychedelics Survey, who will provide a look at how her survey data intersects with that of the BCSP’s. Attendees will have the opportunity to hear directly from the researchers about the findings and ask questions about what they may mean for the future of psychedelic policy, research and education. Registration is free and open to the public: https://berkeley.zoom.us/webinar/register/WN_S2laufU_TSqzBfJAv15Cdg#/registration
The full 2025 report, a Q&A with our research scientist, registration to the webinar and the prior 2023 report, can be found at psychedelics.berkeley.edu/survey. Andrea Venezia (report author and Executive Director of the BCSP) and Tyrone Sgambati (report author and postdoctoral research scientist) are available for interviews.
Figures, tables or infographics available here. Alternative sizes or graphics upon request.
Media Contact:
Rana Freedman, Executive Director of Communications
Email: bcspmedia@berkeley.edu
About the UC Berkeley Center for the Science of Psychedelics
The UC Berkeley Center for the Science of Psychedelics (BCSP) is an academic research center dedicated to the advancement of psychedelic discovery for the public good. The BCSP serves as a leading trusted source for scientific and interdisciplinary inquiry through rigorous scientific research, balanced journalism, accessible public education and reciprocal community engagement. The BCSP envisions a world in which progress in psychedelic research, public education, policy and practice lead to improvements in health and well-being. The BCSP is guided by the values and principles of acting with integrity and transparency, conducting rigorous research, serving as responsible stewards of public resources, embodying equity and reciprocity, and approaching the work with curiosity. For more information, visit psychedelics.berkeley.edu.












